Go to the content

Leuven-based Qaelum NV and German Ulrich medical enter into a strategic partnership

2 December 2021

Qaelum NV announced that they enter into a strategic partnership with ulrich GmbH & Co. KG in Ulm to combine their advanced Contrast Management solution with the contrast media injectors of ulrich medical, to support the needs of hospitals and imaging networks.

Qaelum

Contrast dose as well as Radiation exposure is an issue for every player in a patient’s treatment, from the patient, to the referring physician, to the radiology department, and to regulatory bodies. The novel Contrast Management solution and Qaelum’s proven Dose Management System will enable organizations to manage, analyse and balance their contrast agents and the patient dose.

Qaelum NV is a Leuven, Belgium-based medical software solutions provider advocating patient safety and quality improvement in medical imaging environments. Begun as an academic project at the University Hospitals of Leuven, it is now the preferred choice for leading European institutions. Qaelum’s mission is to help various social healthcare stakeholders, from patients and healthcare professionals to regulators, in creating patient safe and optimized medical imaging environments. Qaelum does this by developing and implementing user-friendly and state of the art software solutions extensively validated by key opinion leaders in the field.

Harmonizing protocols and improving quality, integrated in the existing PACS environment

With this strategic alliance, ulrich medical will offer a flexible solution that allows for central recording and statistical data processing of the utilization of the connected contrast injectors at enterprise level. Contrast usage can be analyzed at different levels, protocols can be harmonized and regulatory reporting needs can be simplified. The vendor-neutral solution needs only a limited time investment of the local IT department and can run both in an on-premise or cloud-based version.


“Qaelum is a leader in Advanced Dose and Contrast Management software solutions,” says Sven Erdmann, Vice President Technology and Regulation of ulrich medical. “Our strategic alliance will allow medical imaging departments to take control over the usage of their contrast media injectors and provide them the tools to harmonize and optimize their injection protocols. By combining the strengths of the quality management tools of Qaelum, with the state-of-the-art solutions of ulrich medical, including our FDA approved DICOM RIS/PACS connection, we can now offer healthcare enterprises a complete solution that will help institutions drive more value from their existing investments, now and into the future.”

“We are delighted to enter into this strategic partnership with ulrich medical,” says Jurgen Jacobs, CEO and co-founder of Qaelum. “This partnership fits perfectly in our long term strategy to improve patient safety, quality and efficiency in medical imaging departments."

Related News

How can we help?

The Leuven MindGate team is at your disposal for any questions about the Leuven Innovation Region. Do you want to invest, work or study in the region? We can help you find your way.

We also facilitate collaboration and innovation between companies, knowledge institutes and government within the Leuven Innovation Region, and we are happy to guide any of these stakeholders towards innovation.